AXS-05 vs Bupropion to prevent depression relapse
Treatments studied
Part of Mental health clinical trials.
This study tests whether a new drug called AXS-05 can prevent depression from coming back, compared to an older drug called bupropion. If you have major depression and are at risk of relapse, this trial may help you stay well.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are currently diagnosed with major depressive disorder, without any hallucinations or delusions (psychotic features).
- Your current depressive episode has lasted at least 4 weeks.
- You have not taken the study drug AXS-05 or the medication Auvelity before.
- You have not taken any experimental drug or been in another clinical trial in the last 30 days.
- You are able to follow all study procedures and your doctor agrees you are medically suitable for the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medication (NBI-1065845) added to your current antidepressant to see if it helps maintain improvement in depression. It is for people whose depression hasn't fully responded to their current oral antidepressant.
This trial tests an investigational drug called NBI-1065845 added to your current antidepressant. It is for people with moderate to severe depression or persistent depressive disorder who have not improved enough with oral antidepressants alone.
This study tests whether bupropion helps children and teens with major depressive disorder (MDD) and checks its safety. You may be able to join if your depression symptoms fit specific scoring and timing rules.
This trial tests a new medication called ABX-002 as an add-on to your current antidepressant. It's for people with moderate to severe depression who haven't gotten enough help from their current antidepressant alone.
This study tests an investigational drug called BMS-986511 in adults with moderate to severe depression. The goal is to see if it can improve symptoms.
This study tests a new oral medication (NBI-1065845) added to your current antidepressant to see if it's safe and tolerable over a long period for people with depression that hasn't fully responded to treatment.
Hear when a new Major Depressive Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.